NewsBenzinga애냅티스바이오, 2분기 조정 주당순손실 0.11달러로 예상치 0.46달러 상회, 매출 2,748만 8천 달러로 예상치 2,167만 5천 달러 상회 애냅티스바이오, 2분기 조정 주당순손실 0.11달러로 예상치 0.46달러 상회, 매출 2,748만 8천 달러로 예상치 2,167만 5천 달러 상회 Benzinga 2026.09.21 20:55 (GMT+0) Open on Benzinga Other news Wells Fargo Maintains Overweight on Essential Properties, Lowers Price Target to $30 Morgan Stanley Maintains Equal-Weight on Sportradar Gr, Lowers Price Target to $13.5 Morgan Stanley Maintains Underweight on Simmons First Ntl, Raises Price Target to $27 Wells Fargo Maintains Equal-Weight on EPR Properties, Lowers Price Target to $56 Analyst Sees Billions in Walmart's Next Big Advertising Opportunity Morgan Stanley Maintains Equal-Weight on Red Rock Resorts, Lowers Price Target to $59
